new
   Indications for Dasatinib (Sprycel)
507
Nov 03, 2025

Dasatinib (Sprycel) is a multi-targeted inhibitor against tyrosine kinases, which exerts anti-cancer effects by blocking multiple key tumor signaling pathways. With its unique "dual mechanism", it can not only act on the active conformation of ABL kinase but also bind to the inactive conformation, thereby effectively overcoming a variety of imatinib-resistant mutations.

Indications for Dasatinib (Sprycel)

Indications for Adult Patients

Newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.

Patients with chronic phase, accelerated phase, or blast phase (myeloid or lymphoid) CML who are resistant or intolerant to previous treatments (including imatinib).

Patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) who are resistant or intolerant to previous treatments.

Indications for Pediatric Patients (Children Aged 1 Year and Older)

Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in chronic phase.

Newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL), which needs to be used in combination with chemotherapy.

Specifications and Properties of Dasatinib (Sprycel)

Appearance Characteristics

All tablets are white to off-white, biconvex, film-coated tablets.

20 mg: Round tablets, engraved with "BMS" on one side and "527" on the other side.

50 mg: Oval tablets, engraved with "BMS" on one side and "528" on the other side.

100 mg: Oval tablets, engraved with "BMS100" on one side and "852" on the other side.

The tablet core contains the active ingredient dasatinib, and the outer layer is coated with a film to reduce the risk of exposure for healthcare workers.

Storage Conditions for Dasatinib (Sprycel)

General Storage Requirements

Storage temperature: 20°C to 25°C (68°F to 77°F).

Short-term storage in an environment of 15°C to 30°C (59°F to 86°F) is permitted.

Precautions for Special Operations

Prohibition of crushing operations: Tablets must not be crushed, split, or chewed; they must be swallowed whole.

Safety Protection Measures

Latex or nitrile gloves must be worn when handling crushed tablets.

Pregnant individuals should avoid contact with broken tablets.

Special disposal procedures must be followed when discarding expired medications.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
RELATED ARTICLES
Contraindications and Special Populations of Brensocatib Tablets

The prescribing information for Brixocatib tablets indicates that there are no absolute contraindications, but...

Friday, August 7th, 2026, 17:16
Dosage and Administration of Isatuximab Injection (Sarclisa)

Sarclisa must be administered under the supervision of a healthcare professional, and the administration site must...

Friday, August 7th, 2026, 14:56
Indications and Dosage of Tepotinib

Tepotinib is an oral MET tyrosine kinase inhibitor indicated for the treatment of non-small cell lung cancer...

Thursday, August 6th, 2026, 15:43
Dosage and Administration of Zidesamtinib

Before the first administration of Ziditnib, the following baseline assessments must be completed:...

Thursday, August 6th, 2026, 15:41
RELATED MEDICATIONS
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved